The translational neural circuitry of anxiety.


Journal

Journal of neurology, neurosurgery, and psychiatry
ISSN: 1468-330X
Titre abrégé: J Neurol Neurosurg Psychiatry
Pays: England
ID NLM: 2985191R

Informations de publication

Date de publication:
12 2019
Historique:
received: 12 06 2019
revised: 17 06 2019
accepted: 17 06 2019
pubmed: 1 7 2019
medline: 12 6 2020
entrez: 1 7 2019
Statut: ppublish

Résumé

Anxiety is an adaptive response that promotes harm avoidance, but at the same time excessive anxiety constitutes the most common psychiatric complaint. Moreover, current treatments for anxiety-both psychological and pharmacological-hover at around 50% recovery rates. Improving treatment outcomes is nevertheless difficult, in part because contemporary interventions were developed without an understanding of the underlying neurobiological mechanisms that they modulate. Recent advances in experimental models of anxiety in humans, such as threat of unpredictable shock, have, however, enabled us to start translating the wealth of mechanistic animal work on defensive behaviour into humans. In this article, we discuss the distinction between fear and anxiety, before reviewing translational research on the neural circuitry of anxiety in animal models and how it relates to human neuroimaging studies across both healthy and clinical populations. We highlight the roles of subcortical regions (and their subunits) such as the bed nucleus of the stria terminalis, the amgydala, and the hippocampus, as well as their connectivity to cortical regions such as dorsal medial and lateral prefrontal/cingulate cortex and insula in maintaining anxiety responding. We discuss how this circuitry might be modulated by current treatments before finally highlighting areas for future research that might ultimately improve treatment outcomes for this common and debilitating transdiagnostic symptom.

Identifiants

pubmed: 31256001
pii: jnnp-2019-321400
doi: 10.1136/jnnp-2019-321400
doi:

Banques de données

ClinicalTrials.gov
['NCT00047853', 'NCT00026559']

Types de publication

Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1353-1360

Subventions

Organisme : Medical Research Council
ID : MR/R020817/1
Pays : United Kingdom
Organisme : Intramural NIH HHS
ID : ZIA MH002798
Pays : United States
Organisme : Medical Research Council
ID : MR/K024280/1
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: OJR has completed consultancy work for Ieso Digital Health and Brainbow and is running an Investigator Initiated Trial with Lundbeck. He holds an MRC Industrial Collaboration Award with Cambridge Cognition.

Auteurs

Oliver J Robinson (OJ)

Institute of Cognitive Neuroscience, University College London, London, UK o.robinson@ucl.ac.uk.
Research Department of Clinical, Educational and Health Psychology, University College London, London, UK.

Alexandra C Pike (AC)

Institute of Cognitive Neuroscience, University College London, London, UK.
Research Department of Clinical, Educational and Health Psychology, University College London, London, UK.

Brian Cornwell (B)

Swinburne University of Technology, Hawthorn, Victoria, Australia.

Christian Grillon (C)

National Institute of Mental Health, Bethesda, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH